Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-10-27 7:27 pm Purchase | 13D | ESTRELLA IMMUNOPHARMA INC ESLA | Eureka Therapeutics Inc. | 25,277,831 71.800% | 25,277,831 (New Position) | View |
| 2023-03-10 4:04 pm Sale | 13G | ESTRELLA IMMUNOPHARMA INC ESLA | Karpus Management Inc. | 0 0.000% | -863,249 (Position Closed) | View |
| 2023-02-14 4:49 pm Sale | 13G | ESTRELLA IMMUNOPHARMA INC ESLA | ATW SPAC MANAGEMENT LLC | 0 0.000% | -390,000 (Position Closed) | View |
| 2023-02-14 4:31 pm Sale | 13G | ESTRELLA IMMUNOPHARMA INC ESLA | Karpus Management Inc. | 863,249 14.750% | -3,002 (-0.35%) | View |
| 2023-01-31 12:33 pm Sale | 13G | ESTRELLA IMMUNOPHARMA INC ESLA | BOOTHBAY FUND MANAGEMENT LLC | 0 0.000% | -390,000 (Position Closed) | View |
| 2022-03-17 4:50 pm Purchase | 13G | ESTRELLA IMMUNOPHARMA INC ESLA | Li Jianwei | 1,253,730 26.440% | 1,253,730 (New Position) | View |
| 2022-02-14 4:27 pm Purchase | 13G | ESTRELLA IMMUNOPHARMA INC ESLA | Karpus Management Inc. | 866,251 14.810% | 87,851 (+11.29%) | View |
| 2022-02-14 07:04 am Purchase | 13G | ESTRELLA IMMUNOPHARMA INC ESLA | ATW SPAC MANAGEMENT LLC | 390,000 6.670% | 390,000 (New Position) | View |
| 2022-02-04 4:18 pm Purchase | 13G | ESTRELLA IMMUNOPHARMA INC ESLA | BOOTHBAY FUND MANAGEMENT LLC | 390,000 6.670% | 390,000 (New Position) | View |
| 2022-02-02 2:21 pm Sale | 13G | ESTRELLA IMMUNOPHARMA INC ESLA | Space Summit Capital LLC | 0 0.000% | -350,000 (Position Closed) | View |
| 2021-10-08 5:13 pm Purchase | 13G | ESTRELLA IMMUNOPHARMA INC ESLA | K2 PRINCIPAL FUND L.P. | 245,593 4.170% | 245,593 (New Position) | View |
| 2021-10-08 4:27 pm Purchase | 13G | ESTRELLA IMMUNOPHARMA INC ESLA | Karpus Management Inc. | 778,400 13.310% | 778,400 (New Position) | View |
| 2021-07-27 08:35 am Sale | 13G | ESTRELLA IMMUNOPHARMA INC ESLA | K2 PRINCIPAL FUND L.P. | 360,446 6.120% | -64,554 (-15.19%) | View |
| 2021-07-22 5:19 pm Purchase | 13G | ESTRELLA IMMUNOPHARMA INC ESLA | Space Summit Capital LLC | 350,000 8.750% | 350,000 (New Position) | View |
| 2021-07-22 4:08 pm Purchase | 13G | ESTRELLA IMMUNOPHARMA INC ESLA | TradeUP Acquisition Sponsor LLC | 1,145,760 19.450% | 1,145,760 (New Position) | View |
| 2021-07-19 5:56 pm Purchase | 13G | ESTRELLA IMMUNOPHARMA INC ESLA | K2 PRINCIPAL FUND L.P. | 425,000 8.030% | 425,000 (New Position) | View |